ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "New Epinephrine Nasal Spray "
Episode Synopsis
Anaphylaxis specialist Jay Lieberman, MD, FAAAAI, tells us everything we need to know about the first FDA approved epinephrine nasal spray to treat type 1 allergic reactions and anaphylaxis. (Participants in this podcast have disclosed a past financial relationship with the drug manufacturer.)
More episodes of the podcast AAAAI Podcast: Conversations from the World of Allergy
Unraveling Mast Cell Activation Syndrome
19/08/2025
Severe Asthma
01/07/2025
New Developments in Eosinophilic Esophagitis
22/05/2025
In God we trust